News
This article is reprinted by permission from NerdWallet. For the first time since 2016, the Free Application for Federal Student Aid (FAFSA) will not...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow I am a dynamic finance professional with a Master’s in Banking & Finance from Université Paris 1 Panthéon-Sorbonne....
News
This article was written by Follow Daniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at...
News
This article was written by Follow Rida Morwa is a former investment and commercial Banker, with over 35 years of experience. He has been...
News
Investment Thesis Trex Company, Inc. (NYSE:TREX) has good revenue and margin growth prospects moving forward. The company should see revenue growth recovery in the...
News
It has been a dreadful 2023 for solar-related and clean energy stocks. The Invesco Solar ETF (TAN) is down 20% total return on the...
News
Thesis Although Endava plc’s (NYSE:DAVA) growth may face challenges in the coming quarters due to ongoing macroeconomic pressures, I have confidence in the company’s...
News
Introduction TC Energy (NYSE:TRP) is a prominent energy infrastructure company operating in the United States, Canada, and Mexico. TC Energy’s main financial drivers are...
News
Trip.com Group Limited (NASDAQ:TCOM) Q2 2023 Earnings Call Transcript September 4, 2023 8:00 PM ET Company Participants Michelle Qi – Investor Relations Director James...
News
Summary Ollie’s Bargain Outlet Holdings (NASDAQ:OLLI) is a retail company that operates stores selling name-brand items at low, closeout prices. Products offered by the...
News
Investors seem to be questioning the sustainability of Winnebago Industries’s (NYSE:WGO) revenue and operating margin gains. Winnebago’s TTM revenues are roughly twice pre-COVID levels,...
News
Founded in 2013, FIGS (NYSE:FIGS) transformed the once bland and unbranded scrub into a fashion item, reaching over $500 million revenue in 2022 along...
News
Introduction Marinus Pharmaceuticals (NASDAQ:MRNS), focusing on seizure disorders, got FDA approval in 2022 for Ztalmy (ganaxolone) to treat seizures in CDD patients over two....
